Can I Stop Taking My NMOSD Medication If I Feel Fine?

Do not stop, skip, or delay a dose of your Neuromyelitis Optica Spectrum Disorder (NMOSD) medication without speaking with your prescribing team.

It is entirely normal to feel “cured” after years without an attack and to want a break from infusions, injections, or pills. However, being symptom-free for a long time does not mean the underlying disease has disappeared; it usually means your medication is effectively protecting your central nervous system.

Sometimes, a neurologist will recommend a planned hold, taper, or switch in medication due to a serious infection, pregnancy planning, or intolerable side effects. But stopping or changing doses on your own is highly risky and can lead to severe relapses.

Why Feeling Well Does Not Mean the Disease is Gone

NMOSD is a chronic autoimmune disease, meaning your immune system is mistakenly programmed to attack your central nervous system. Preventative treatments—which include general immunosuppressants or newer targeted immune therapies (medications designed to block specific parts of the immune system)—work to keep this response in check.

Research indicates that disease activity can return if treatment is stopped. In one observational study of 343 NMOSD patients, 77.5% experienced a relapse after withdrawing their immunosuppressant medication ^[1]. Conversely, long-term trials show high success rates when targeted treatments are continued; for example, in an open-label extension study of predominantly AQP4-positive patients taking the complement-blocking drug eculizumab, over 94% remained relapse-free at nearly four years ^[2]. Experts emphasize that maintenance immunotherapy should remain the standard approach for most patients, as unpredictable relapses can occur even after a decade of stability ^[3].

The Risks of Relapse

In NMOSD, relapses are the main source of lasting disability. While attacks vary widely and not every attack causes severe permanent damage, some can lead to lasting vision loss, weakness, or breathing problems ^[4].

Even a single relapse can lead to significantly worse long-term disability and lower quality of life ^[5]. Because early treatment of a suspected attack is highly time-sensitive, the primary goal of maintenance therapy is to prevent these attacks from happening in the first place.

Warning Signs of a Possible Attack

Seek Same-Day Urgent or Emergency Care If You Experience:

• New or worsening vision loss or eye pain
• New weakness, numbness, or trouble walking
• New bladder or bowel dysfunction
• Persistent, unexplained nausea, vomiting, or hiccups
• Confusion or difficulty breathing

Do not wait for a routine appointment if you develop these symptoms. Breathing difficulty or rapidly worsening neurological symptoms require immediate emergency care.

Understanding Your Specific Risk

Treatment considerations often depend on your specific NMOSD subtype. For instance, testing positive for the AQP4-IgG antibody (a blood marker used to identify the most common NMOSD subtype) is a known risk factor for return of disease activity if treatment is interrupted.

For patients taking B-cell-depleting therapies (treatments like rituximab that reduce specific immune cells called B-cells), delaying or missing doses is associated with a higher risk of relapses ^[6]. These relapses frequently occur just as the B-cells begin to return, or “repopulate,” in the blood ^[7]. However, laboratory B-cell results should not be used to time your own doses, as B-cell return does not guarantee an immediate relapse, and relapses can sometimes happen even before B-cells are easily detectable.

What If Side Effects Are the Problem?

Long-term immunosuppression can cause legitimate hardships, including severe or opportunistic infections, fatigue, and other quality-of-life impacts ^[8]. If you are considering stopping because the side effects or treatment logistics are intolerable, your feelings are completely valid.

Instead of skipping your next dose, contact your prescribing neurologist or infusion team. In the United States and many other countries, there are several FDA-approved preventative treatments specifically for AQP4-positive adults. If your current medication is not working for you, a specialist-supervised switch might be possible. Keep in mind that different treatments require different precautions—for instance, some require specific vaccinations (like meningococcal vaccines for complement inhibitors), while others require regular blood counts, liver tests, or immunoglobulin monitoring. Your care team can help you find a safer balance.